Titan Biotech Limited (TITANBIO.BO)
INR 456.8
(-0.87%)
INR 456.8
(-0.87%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.64 Billion INR | 13.94% |
| 2022 | 1.43 Billion INR | -5.77% |
| 2021 | 1.52 Billion INR | 7.43% |
| 2020 | 1.42 Billion INR | 79.05% |
| 2019 | 794.37 Million INR | 22.39% |
| 2018 | 649.08 Million INR | 13.13% |
| 2017 | 573.74 Million INR | 8.89% |
| 2016 | 526.91 Million INR | 15.12% |
| 2015 | 457.7 Million INR | 13.53% |
| 2014 | 403.16 Million INR | 3.02% |
| 2013 | 391.33 Million INR | 44.53% |
| 2012 | 270.75 Million INR | 20.24% |
| 2011 | 225.17 Million INR | 20.53% |
| 2010 | 186.81 Million INR | 16.27% |
| 2009 | 160.67 Million INR | 19.56% |
| 2008 | 134.38 Million INR | 9.07% |
| 2007 | 123.2 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 431.14 Million INR | 8.01% |
| 2023 Q2 | 434.27 Million INR | 24.98% |
| 2023 Q1 | 347.47 Million INR | -5.67% |
| 2023 Q4 | 399.18 Million INR | -13.18% |
| 2023 FY | 1.64 Billion INR | 13.94% |
| 2023 Q3 | 459.78 Million INR | 5.88% |
| 2022 Q3 | 303.33 Million INR | -27.49% |
| 2022 Q4 | 368.36 Million INR | 21.44% |
| 2022 FY | 1.43 Billion INR | -5.77% |
| 2022 Q1 | 349.96 Million INR | 1.29% |
| 2022 Q2 | 418.33 Million INR | 19.54% |
| 2021 Q1 | 414.39 Million INR | 16.52% |
| 2021 FY | 1.52 Billion INR | 7.43% |
| 2021 Q2 | 420.07 Million INR | 1.37% |
| 2021 Q3 | 364.26 Million INR | -13.28% |
| 2021 Q4 | 345.49 Million INR | -5.15% |
| 2020 FY | 1.42 Billion INR | 79.05% |
| 2020 Q2 | 326.56 Million INR | -17.16% |
| 2020 Q3 | 345.97 Million INR | 5.94% |
| 2020 Q4 | 355.65 Million INR | 2.8% |
| 2020 Q1 | 394.18 Million INR | 96.32% |
| 2019 FY | 794.37 Million INR | 22.39% |
| 2019 Q1 | 220.93 Million INR | 56.9% |
| 2019 Q2 | 185.06 Million INR | -16.24% |
| 2019 Q3 | 187.59 Million INR | 1.37% |
| 2019 Q4 | 200.78 Million INR | 7.03% |
| 2018 Q3 | 149.11 Million INR | -12.36% |
| 2018 Q4 | 140.81 Million INR | -5.57% |
| 2018 Q2 | 170.14 Million INR | 8.24% |
| 2018 Q1 | 157.19 Million INR | 4.28% |
| 2018 FY | 649.08 Million INR | 13.13% |
| 2017 Q3 | 153.68 Million INR | -1.18% |
| 2017 FY | 573.74 Million INR | 8.89% |
| 2017 Q4 | 150.74 Million INR | -1.92% |
| 2017 Q2 | 155.52 Million INR | 22.14% |
| 2017 Q1 | 127.32 Million INR | -15.43% |
| 2016 Q4 | 150.56 Million INR | 21.88% |
| 2016 FY | 526.91 Million INR | 15.12% |
| 2016 Q1 | 120.01 Million INR | -4.68% |
| 2016 Q3 | 123.53 Million INR | -7.31% |
| 2016 Q2 | 133.27 Million INR | 11.06% |
| 2015 FY | 457.7 Million INR | 13.53% |
| 2015 Q4 | 125.9 Million INR | 9.38% |
| 2015 Q3 | 115.1 Million INR | -4.09% |
| 2015 Q2 | 120.01 Million INR | 28.6% |
| 2015 Q1 | 93.32 Million INR | -21.99% |
| 2014 Q1 | 88.73 Million INR | -20.21% |
| 2014 FY | 403.16 Million INR | 3.02% |
| 2014 Q3 | 83.04 Million INR | -25.7% |
| 2014 Q2 | 111.76 Million INR | 25.95% |
| 2014 Q4 | 119.62 Million INR | 44.06% |
| 2013 Q2 | 122.14 Million INR | 88.9% |
| 2013 Q4 | 111.21 Million INR | 19.17% |
| 2013 Q1 | 64.66 Million INR | -13.33% |
| 2013 Q3 | 93.31 Million INR | -23.6% |
| 2013 FY | 391.33 Million INR | 44.53% |
| 2012 Q4 | 74.6 Million INR | 9.9% |
| 2012 Q1 | 57.74 Million INR | -23.51% |
| 2012 Q2 | 70.52 Million INR | 22.14% |
| 2012 Q3 | 67.88 Million INR | -3.75% |
| 2012 FY | 270.75 Million INR | 20.24% |
| 2011 Q4 | 75.48 Million INR | 58.6% |
| 2011 Q3 | 47.59 Million INR | 0.0% |
| 2011 FY | 225.17 Million INR | 20.53% |
| 2010 Q4 | 53.68 Million INR | 0.0% |
| 2010 FY | 186.81 Million INR | 16.27% |
| 2009 FY | 160.67 Million INR | 19.56% |
| 2008 FY | 134.38 Million INR | 9.07% |
| 2008 Q4 | 33.19 Million INR | 0.0% |
| 2007 FY | 123.2 Million INR | 0.0% |
| 2007 Q4 | 33.6 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 31.27 Million INR | -5146.446% |
| Biocon Limited | 147.55 Billion INR | 98.888% |
| Blue Jet Healthcare Limited | 7.11 Billion INR | 76.943% |
| Concord Biotech Limited | 10.16 Billion INR | 83.866% |
| Dishman Carbogen Amcis Limited | 26.15 Billion INR | 93.728% |
| FERMENTA BIOTECH LIMITED | 3.35 Billion INR | 51.12% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.65 Million INR | -99292.458% |
| Lyka Labs Limited | 1.05 Billion INR | -56.063% |
| Panacea Biotec Limited | 5.51 Billion INR | 70.273% |
| SAMSRITA LABS LIMITED | - INR | -Infinity% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 3.05 Billion INR | 46.374% |
| Supriya Lifescience Limited | 5.7 Billion INR | 71.234% |
| Syngene International Limited | 34.88 Billion INR | 95.297% |
| TAKE Solutions Limited | 656.08 Million INR | -150.079% |
| Transgene Biotek Limited | 2.34 Million INR | -69747.637% |
| Vanta Bioscience Limited | 97.22 Million INR | -1587.481% |